A shadow market for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.
Investigational Drug Acquiring Traction Via Social Media
Retatrutide, which is still in research studies, is being promoted by online personalities for its alleged fat-burning effects. Followers are urged to contact these profiles privately for supplier links, while also obtaining promotional offers.
Thriving Commerce on Social Networks
Separately, a robust trade exists on Telegram, where communities with thousands of participants share comparison photos, administration instructions and claims of rapid UK delivery. Vendors market the substance there before directing buyers to WhatsApp for transactions.
Learning About The Experimental Drug
Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.
Healthcare Professionals Voice Concerns
Nevertheless, doctors and pharmacists have cautions that the sale of what remains an unapproved drug in the United Kingdom is worrisome and could result in individuals injecting substances of uncertain source.
Some professionals stated the popularity for the experimental drug could be linked to the rising price of approved slimming treatments such as Mounjaro.
Legal Position and Implementation
Selling the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.
Some content creators try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still breach medicines, advertising, and consumer regulations, potentially leading to penalties, legal action or imprisonment.
Platform Reaction and Content Elimination
Based on TikTok, the platform has removed violative content and prohibited associated keywords and search suggestions. The organization stated it was dedicated to keeping the service secure and allocating resources in enhancing compliance measures.
Online Trading Operations
Investigations also found communities with up to nine thousand members marketing retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays channels with thousands of members, filled with images of weight loss, positive reviews and detailed instructions for preparing or injecting at home.
Within minutes of joining one community, a vendor posted contact information, where most purchases take place. The seller sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. None asked about weight, medical conditions or past usage.
Product Details and Costs
Within these groups, messages display dark colored packages with postal service stickers, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at residence with sterile water, or pre-filled pens typically priced at £160 for 20 milligrams. When asked how much time a injector should be used, vendors give contradictory responses varying between a several days to “depends on your body”.
Service Oversight and Safety Measures
A spokesperson for the messaging service stated it regularly monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are injecting materials they cannot confirm. Although the science behind this drug is valid, these online versions may not include what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor linked the increase in interest to recent price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she said.
Her team has already seen patients harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or communication platforms is taking chances with your well-being,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may expose patients to potentially significant health risks”.
